Abstract:Accurate diagnosis in early stage is vital for the treatment of Hepatocellular carcinoma. The aim of this study was to investigate the potential of poly lactic acid-polyethylene glycol/gadolinium-diethylenetriamine-pentaacetic acid (PLA-PEG/Gd-DTPA) nanocomplexes using as biocompatible molecular magnetic resonance imaging (MRI) contrast agent. The PLA-PEG/Gd-DTPA nanocomplexes were obtained using self-assembly nanotechnology by incubation of PLA-PEG nanoparticles and the commercial contrast agent, Gd-DTPA. The physicochemical properties of nanocomplexes were measured by atomic force microscopy and photon correlation spectroscopy. The T(1)-weighted MR images of the nanocomplexes were obtained in a 3.0 T clinical MR imager. The stability study was carried out in human plasma and the distribution in vivo was investigated in rats. The mean size of the PLA-PEG/Gd-DTPA nanocomplexes was 187.9 +/- 2.30 nm, and the polydispersity index was 0.108, and the zeta potential was -12.36 +/- 3.58 mV. The results of MRI test confirmed that the PLA-PEG/Gd-DTPA nanocomplexes possessed the ability of MRI, and the direct correlation between the MRI imaging intensities and the nano-complex concentrations was observed (r = 0.987). The signal intensity was still stable within 2 h after incubation of the nanocomplexes in human plasma. The nanocomplexes gave much better image contrast effects and longer stagnation time than that of commercial contrast agent in rat liver. A dose of 0.04 mmol of gadolinium per kilogram of body weight was sufficient to increase the MRI imaging intensities in rat livers by five-fold compared with the commercial Gd-DTPA. PLA-PEG/Gd-DTPA nanocomplexes could be prepared easily with small particle sizes. The nanocomplexes had high plasma stability, better image contrast effect, and liver targeting property. These results indicated that the PLA-PEG/Gd-DTPA nanocomplexes might be potential as molecular targeted imaging contrast agent.

PEGylated GdF3:Fe Nanoparticles As Multimodal T1/T2-Weighted MRI and X-ray CT Imaging Contrast Agents.

PEGylated GdF 3 :Fe Nanoparticles as Multimodal T 1 /T 2 -Weighted MRI and X-ray CT Imaging Contrast Agents.

Ultra-Small and Metabolizable Near-Infrared Au/Gd Nanoclusters for Targeted FL/MRI Imaging and Cancer Theranostics

A Synergistically Enhanced T-1 And T-2-Weighted Magnetic Resonance/Near-Infrared Contrast Agent Of Gd-Doping Fe3o4@Fluorescence Pegylated Nanoparticles For Multimodality Imaging Of Hepatocarcinoma

Synthesis of PEGylated BaGdF5 Nanoparticles As Efficient CT/MRI Dual-modal Contrast Agents for Gastrointestinal Tract Imaging

Targeted Dual-Contrast T1- and T2-weighted Magnetic Resonance Imaging of Tumors Using Multifunctional Gadolinium-Labeled Superparamagnetic Iron Oxide Nanoparticles

A Targeted Nanoglobular Contrast Agent from Host-Guest Self-Assembly for MR Cancer Molecular Imaging.

Magnetic Resonance Imaging Contrast Agent: Crgd-Ferric Oxide Nanometer Particle and Its Role in the Diagnosis of Tumor

Three-Dimensional Angiography Fused With Ct/Mri For Multimodal Imaging Of Nanoparticles Based On Ba4yb3f17:Lu3+,Gd3+

Multifunctional Gadolinium-Labeled Silica-Coated Fe3o4 And Cuins2 Nanoparticles As A Platform For In Vivo Tri-Modality Magnetic Resonance And Fluorescence Imaging

An Ultrasmall and Metabolizable PEGylated NaGdF4:Dy Nanoprobe for High-Performance T(1)/T(2)-weighted MR and CT Multimodal Imaging.

Tumor-penetrating Peptide Conjugated and Doxorubicin Loaded T1-T2 Dual Mode MRI Contrast Agents Nanoparticles for Tumor Theranostics

Gadolinium‐conjugated FA‐PEG‐PAMAM‐COOH Nanoparticles As Potential Tumor‐targeted Circulation‐prolonged Macromolecular MRI Contrast Agents

Gadolinium-conjugated folate-poly(ethylene glycol)-polyamidoamine dendrimer-carboxyl nanoparticles as potential tumor-targeted, circulation-prolonged macromolecular magnetic resonance imaging contrast agents. II

Poly(Acrylic Acid) Bridged Gadolinium Metal-Organic Framework-Gold Nanoparticle Composites As Contrast Agents for Computed Tomography and Magnetic Resonance Bimodal Imaging

Gadolinium-chelate functionalized bismuth nanotheranostic agent for in vivo MRI/CT/PAI imaging-guided photothermal cancer therapy.

Albumin-based Nanoparticles Loaded with Hydrophobic Gadolinium Chelates As T1-T2 Dual-Mode Contrast Agents for Accurate Liver Tumor Imaging.

Pegylated Hybrid Ytterbia Nanoparticles As High-Performance Diagnostic Probes for in Vivo Magnetic Resonance and X-Ray Computed Tomography Imaging with Low Systemic Toxicity

Core-Satellite Polydopamine-Gadolinium-Metallofullerene Nanotheranostics for Multimodal Imaging Guided Combination Cancer Therapy

One-Step Loading of Gold and Gd2O3 Nanoparticles Within PEGylated Polyethylenimine for Dual Mode Computed Tomography/Magnetic Resonance Imaging of Tumors.

Biocompatible Nanocomplexes for Molecular Targeted MRI Contrast Agent